succinylacetone has been researched along with Autoimmune Disease in 1 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
Excerpt | Relevance | Reference |
---|---|---|
"The effects of succinylacetone (SA) on the development of S-antigen-induced experimental autoimmune uveitis (EAU) in the rat were studied." | 7.67 | Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone. ( Blaese, RM; Hess, RA; Nussenblatt, RB; Palestine, AG; Skolik, SA, 1988) |
"The effects of succinylacetone (SA) on the development of S-antigen-induced experimental autoimmune uveitis (EAU) in the rat were studied." | 3.67 | Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone. ( Blaese, RM; Hess, RA; Nussenblatt, RB; Palestine, AG; Skolik, SA, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Skolik, SA | 1 |
Palestine, AG | 1 |
Blaese, RM | 1 |
Nussenblatt, RB | 1 |
Hess, RA | 1 |
1 other study available for succinylacetone and Autoimmune Disease
Article | Year |
---|---|
Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone.
Topics: Animals; Autoimmune Diseases; Dose-Response Relationship, Drug; Female; Heptanoates; Heptanoic Acids | 1988 |